Search Result "clopidogrel besylate"
Generic Clopidogrel Besylate in the Secondary Prevention of Atherothrombotic Events: A 6-month Follow-up of a Randomised Clinical Trial
Journal: Current Vascular Pharmacology
Volume: 13 Issue: 6 Year: 2015 Page: 809-818
Author(s): Ioannis V. Ntalas, Kalliroi I. Kalantzi, Maria E. Tsoumani, John N. Vakalis, Vasileios Vasilakopoulos, Konstantinos Vardakis, Konstantinos N. Vemmos, Maria Voukelatou, Georgios Giannakoulas, Ioannis Giatrakos, Vasileios Giogiakas, Georgios Goumas, Nikos Dimoulis, Antonios Draganigos, Ioannis Efthimiadis, Maria Thoma, Evangelos Kazakos, Nikolaos Kipouridis, Spiros Konstantinou, Haralampos Milionis, Adamantios Bourdakis, Dimitrios Nikolopoulos, Leonidas Peltekis, Nikos Prokopakis, Ioannis Sinteles, Christos S. Stroumbis, Kyriafina Terzoudi, Karmelos Tsilias, Ioannis Xaraktsis, Christos Charmpas, Georgios Hatziathanasiou, Zacharias Christogiannis, Demosthenes B. Panagiotakos, John A. Goudevenos, Alexandros D. Tselepis
Clopidogrel Generic Formulations in the Era of New Antiplatelets: A Systematic Review
Journal: Current Vascular Pharmacology
Volume: 12 Issue: 5 Year: 2014 Page: 766-777
Author(s): Maria E. Tsoumani,Kallirroi I. Kalantzi,Ioannis A. Goudevenos,Alexandros D. Tselepis
Duration of Dual Antiplatelet Therapy After Coronary Stenting
Journal: Current Pharmaceutical Design
Volume: 22 Issue: 2 Year: 2016 Page: 4583-4595
Author(s): Gerasimos Siasos, Konstantinos Mourouzis, Evangelos Oikonomou, Manolis Vavuranakis, Georgia Vogiatzi, Alexandros Briasoulis, Nikolaos Papageorgiou, Theodore G. Papaioannou, Thodoris Zografos, Angeliki Papapanagiotou, Athanasios G. Papavassiliou, Christodoulos Stefanadis, Dimitris Tousoulis
Pharmacological Interactions of Paraoxonase 1 (PON1): A HDL-Bound Antiatherogenic Enzyme
Journal: Current Clinical Pharmacology
Volume: 11 Issue: 4 Year: 2016 Page: 259-264
Author(s): Abdolkarim Mahrooz
Combination Secondary Prevention Therapies in Vascular Diseases
Journal: Vascular Disease Prevention
Volume: 2 Issue: 1 Year: 2005 Page: 17-19
Author(s): Stanley Chetcuti, Debabrata Mukherjee
Understanding the Molecular Properties and Metabolism of Top Prescribed Drugs
Journal: Current Topics in Medicinal Chemistry
Volume: 13 Issue: 11 Year: 2013 Page: 1290-1307
Author(s): Haizhen A. Zhong,Victoria Mashinson,Theodor A. Woolman,Mengyi Zha
Impurities Present in Cardiovascular Active Substances and MedicinalProducts: A Pharmacopoeial Perspective
Journal: Current Chromatography
Volume: 9 Issue: 1 Year: 2022 Page: 63-77
Author(s): Arvind K. Sharma,Ramesh K. Goyal
Role of Chiral Ionic Liquids in Enantioseparations Using Capillary Electrophoresis
Ebook: Chiral Ionic Liquids: Applications in Chemistry and Technology
Volume: 1 Year: 2024
Author(s): Ashok Kumar Malik
Doi: 10.2174/9789815305784124010007
Multi-Constituent Cardiovascular Pills (MCCP) - Challenges and Promises of Population-Based Prophylactic Drug Therapy for Prevention of Heart Attack
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 1 Year: 2007 Page: 1069-1076
Author(s): Michael J. Jamieson, Morteza Naghavi
Medical Management of the Diabetic Patient with Coronary Artery Disease
Journal: Current Pharmaceutical Design
Volume: 14 Issue: 2 Year: 2008 Page: 2527-2536
Author(s): Kalypso Karastergiou, Juan Carlos Kaski